FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983149241> ?p ?o ?g. }

• W1983149241 endingPage "S192" @default.
• W1983149241 startingPage "S192" @default.
• W1983149241 abstract "The objective of this investigation was to assess the use of performance enhancing supplements and side effects in Division II athletes at a Historically Black University (HBCU). Assessments of side effects of performance enhancing supplements are limited due to the inability to assess responses to the actual quantities consumed. Furthermore, little has been done to assess utilization of performance enhancing supplements at HBCUs. A two-part survey was developed to assess recreational drug use and performance enhancing supplement consumption and associated side effects. The survey was administered to 71 male and 41 female (age 20.3 ± 1.5 years) varsity athletes. Ninety-five percent of the athletes that completed the survey identified their race/ethnicity as African American. Athletes participated in football (39.3 percent), football and one additional sport (7.2 percent), basketball (n = 23.2 percent), track (1.8 percent), softball (9.8 percent), tennis (2.7 percent), cheerleading (6.3 percent), and volleyball (8.0 percent). No female athletes responded to the use of any type of performance enhancing supplement. Fifteen athletes that participated in football, two in basketball and one in track responded positively to creatine supplementation. The athletes responded they consumed recommended amounts or were unsure of the amount consumed. Three athletes complained of dehydration, two of diarrhea, one of anxiety/mood changes, one of increased heart rate at rest, one of cramping, and two of other side effects that were not identified in response to creatine supplementation. Two athletes that participated in football responded to supplementing androstendione. Neither reported dose or frequency of supplementation. One identified headaches as a side effect of androstendione supplementation. No athletes responded to the use of anabolic steroids. Creatine was the most popular performance-enhancing supplement in the present investigation. The amount of creatine consumed was inconsistent among the athletes. The reported side effects suggest an association between creatine supplementation and multiple systems side effects. More data needs to be collected to assess complications of creatine supplementation." @default.
• W1983149241 created "2016-06-24" @default.
• W1983149241 creator A5006805843 @default.
• W1983149241 creator A5035170002 @default.
• W1983149241 creator A5041386405 @default.
• W1983149241 date "2002-05-01" @default.
• W1983149241 modified "2023-09-25" @default.
• W1983149241 title "PERFORMANCE ENHANCING SUPPLEMENT USE AND SIDE EFFECTS IN DIVISION II ATHLETES AT A HISTORICALLY BLACK UNIVERSITY" @default.
• W1983149241 doi "https://doi.org/10.1097/00005768-200205001-01081" @default.
• W1983149241 hasPublicationYear "2002" @default.
• W1983149241 type Work @default.
• W1983149241 sameAs 1983149241 @default.
• W1983149241 citedByCount "0" @default.
• W1983149241 crossrefType "journal-article" @default.
• W1983149241 hasAuthorship W1983149241A5006805843 @default.
• W1983149241 hasAuthorship W1983149241A5035170002 @default.
• W1983149241 hasAuthorship W1983149241A5041386405 @default.
• W1983149241 hasBestOaLocation W19831492411 @default.
• W1983149241 hasConcept C103189561 @default.
• W1983149241 hasConcept C166957645 @default.
• W1983149241 hasConcept C17744445 @default.
• W1983149241 hasConcept C1862650 @default.
• W1983149241 hasConcept C199539241 @default.
• W1983149241 hasConcept C2778444522 @default.
• W1983149241 hasConcept C2780733359 @default.
• W1983149241 hasConcept C2781054738 @default.
• W1983149241 hasConcept C70410870 @default.
• W1983149241 hasConcept C71924100 @default.
• W1983149241 hasConcept C95457728 @default.
• W1983149241 hasConceptScore W1983149241C103189561 @default.
• W1983149241 hasConceptScore W1983149241C166957645 @default.
• W1983149241 hasConceptScore W1983149241C17744445 @default.
• W1983149241 hasConceptScore W1983149241C1862650 @default.
• W1983149241 hasConceptScore W1983149241C199539241 @default.
• W1983149241 hasConceptScore W1983149241C2778444522 @default.
• W1983149241 hasConceptScore W1983149241C2780733359 @default.
• W1983149241 hasConceptScore W1983149241C2781054738 @default.
• W1983149241 hasConceptScore W1983149241C70410870 @default.
• W1983149241 hasConceptScore W1983149241C71924100 @default.
• W1983149241 hasConceptScore W1983149241C95457728 @default.
• W1983149241 hasIssue "5" @default.
• W1983149241 hasLocation W19831492411 @default.
• W1983149241 hasLocation W19831492412 @default.
• W1983149241 hasOpenAccess W1983149241 @default.
• W1983149241 hasPrimaryLocation W19831492411 @default.
• W1983149241 hasRelatedWork W1997506940 @default.
• W1983149241 hasRelatedWork W2019790481 @default.
• W1983149241 hasRelatedWork W2350775915 @default.
• W1983149241 hasRelatedWork W2357151527 @default.
• W1983149241 hasRelatedWork W2369236739 @default.
• W1983149241 hasRelatedWork W2803966683 @default.
• W1983149241 hasRelatedWork W2954695573 @default.
• W1983149241 hasRelatedWork W3041726547 @default.
• W1983149241 hasRelatedWork W384117815 @default.
• W1983149241 hasRelatedWork W4288039725 @default.
• W1983149241 hasVolume "34" @default.
• W1983149241 isParatext "false" @default.
• W1983149241 isRetracted "false" @default.
• W1983149241 magId "1983149241" @default.
• W1983149241 workType "article" @default.